A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech’s application to offer booster shots to the general public.
Home » News, Insights & Trends » Business » A key part of Biden’s plan to combat Covid is at risk as FDA meets to debate booster shots
A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech’s application to offer booster shots to the general public.
Sign up for free or use coupon code 1BW50 for 50% discount on your subscription
Sign up now